Rituximab-induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti-rituximab antibodies

Br J Haematol. 2019 Mar;184(5):858-861. doi: 10.1111/bjh.15177. Epub 2018 Mar 12.
No abstract available

Keywords: adverse drug reaction; antibodies to rituximab; rituximab: serum sickness; thrombotic thrombocytopenic purpura.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies / blood*
  • Female
  • Humans
  • Middle Aged
  • Purpura, Thrombotic Thrombocytopenic* / blood
  • Purpura, Thrombotic Thrombocytopenic* / drug therapy
  • Rituximab / administration & dosage
  • Rituximab / adverse effects*
  • Serum Sickness* / blood
  • Serum Sickness* / chemically induced

Substances

  • Antibodies
  • Rituximab